CytoDyn Inc. SEC filings CYDY
CytoDyn Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 15, 2015. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 14, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 14, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Apr 8, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Jan 9, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 10, 2025 | Aug 31, 2025 |
| 10-Q | Quarterly report | Apr 14, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Jan 14, 2025 | Nov 30, 2024 |
| 10-Q | Quarterly report | Oct 15, 2024 | Aug 31, 2024 |
| 10-Q | Quarterly report | Apr 15, 2024 | Feb 29, 2024 |
| 10-Q | Quarterly report | Jan 16, 2024 | Nov 30, 2023 |
| 10-Q | Quarterly report | Oct 23, 2023 | Aug 31, 2023 |
| 10-Q | Quarterly report | Apr 10, 2023 | Feb 28, 2023 |
| 10-Q | Quarterly report | Jan 9, 2023 | Nov 30, 2022 |
| 10-Q/A | Amended quarterly report | Oct 13, 2022 | Aug 31, 2022 |
| 10-Q | Quarterly report | Oct 11, 2022 | Aug 31, 2022 |
| 10-Q | Quarterly report | Apr 11, 2022 | Feb 28, 2022 |
| 10-Q | Quarterly report | Jan 10, 2022 | Nov 30, 2021 |
| 10-Q | Quarterly report | Oct 12, 2021 | Aug 31, 2021 |
| 10-Q | Quarterly report | Apr 14, 2021 | Feb 28, 2021 |
| 10-Q | Quarterly report | Jan 8, 2021 | Nov 30, 2020 |
| 10-Q | Quarterly report | Oct 9, 2020 | Aug 31, 2020 |
| 10-Q | Quarterly report | Apr 9, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 9, 2020 | Nov 30, 2019 |
| 10-Q | Quarterly report | Oct 8, 2019 | Aug 31, 2019 |
| 10-Q | Quarterly report | Apr 9, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 9, 2019 | Nov 30, 2018 |
| 10-Q | Quarterly report | Oct 9, 2018 | Aug 31, 2018 |
| 10-Q | Quarterly report | Apr 9, 2018 | Feb 28, 2018 |
| 10-Q | Quarterly report | Jan 8, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Oct 10, 2017 | Aug 31, 2017 |
| 10-Q | Quarterly report | Apr 13, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 13, 2017 | Nov 30, 2016 |
| 10-Q | Quarterly report | Oct 12, 2016 | Aug 31, 2016 |
| 10-Q | Quarterly report | Apr 13, 2016 | Feb 29, 2016 |
| 10-Q | Quarterly report | Jan 11, 2016 | Nov 30, 2015 |
| 10-Q | Quarterly report | Oct 9, 2015 | Aug 31, 2015 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYDY (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Vancouver, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1175680
- Former names
- CYTODYN INC (until Apr 13, 2016); REXRAY CORP (until Nov 12, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.